These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2999572)

  • 1. Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.
    Holmes PJ; Hallworth JA; Stocker DI; Skinner GR
    Med Microbiol Immunol; 1985; 174(4):167-75. PubMed ID: 2999572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin.
    Shivers JC; Daniels CA
    Arch Virol; 1979; 59(1-2):89-97. PubMed ID: 218539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM.
    Yoshino K; Urayama M; Abe K
    Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-idiotypic antibodies to the herpes simplex type-1 virus neutralize the virus' infectious activity].
    Kushch AA; Posevaia TA; Simonov VI; Daniliuk OS; Barinskiĭ IF
    Vopr Virusol; 1991; 36(4):312-5. PubMed ID: 1665620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for the detection of IgG antibodies to herpes simplex virus and its use as a prognostic indicator of HSV excretion in transplant recipients.
    Berry NJ; Grundy JE; Griffiths PD
    J Med Virol; 1987 Feb; 21(2):147-54. PubMed ID: 3029319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for common antigens in herpes simplex and varicella-zoster viruses.
    Schmidt NJ
    J Med Virol; 1982; 9(1):27-36. PubMed ID: 6278070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
    Van Kessel KP; Van Kats-Renaud HJ; Van Strijp JA; Visser MR; Verhoef J
    J Immunol Methods; 1986 Apr; 88(1):101-7. PubMed ID: 3007623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL; Shore SL
    Infect Immun; 1981 Mar; 31(3):1054-61. PubMed ID: 6262246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody to herpes simplex virus by a novel neutralization method with peroxidase-labelled complement Clq.
    Taguchi F; Kawasaki T; Matsuzaki T; Lee SM
    J Virol Methods; 1991 May; 32(2-3):157-62. PubMed ID: 1651947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-requiring neutralizing antibody in guinea pigs with primary and recurrent genital herpes.
    Zheng ZM; Hsiung GD
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):332-6. PubMed ID: 6091148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of herpes simplex virus type 1 (HSV-1) plaque enlargement by neutralizing sera.
    Mannini-Palenzona A; Costanzo F; Foà-Tomasi L; Negosanti M; Lanzoni A
    Microbiologica; 1989 Jul; 12(3):231-40. PubMed ID: 2476650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus microneutralization: a simplification of the test.
    Stalder H; Oxman MN; Herrmann KL
    J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.
    Kutinová L; Vonka V
    Infect Immun; 1978 Jun; 20(3):587-91. PubMed ID: 78899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-idiotypic antibodies against antibodies to the herpes simplex virus and its early antigens].
    Kosiakova NP; Pavliuchenkova RP; Posevaia TA
    Vopr Virusol; 1991; 36(2):133-7. PubMed ID: 1652868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
    Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
    Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.
    Nick S; Kampe P; Knoblich A; Metzger B; Falke D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1015-24. PubMed ID: 3011967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.